Tackling comorbidity associated with rheumatic diseases in standard practice

Area of Science:

• Rheumatology
• Clinical Medicine
• Public Health

Background:

• Inflammatory arthritis patients face reduced lifespan compared to the general population.
• Comorbidities such as cardiovascular disease, infections, and cancers significantly contribute to mortality.
• Current clinical guidelines emphasize comorbidity assessment but face implementation challenges.

Purpose of the Study:

• To review the challenges associated with comorbidity in inflammatory arthritis.
• To discuss the dynamic nature and impact of comorbidities on patient management.
• To explore recent trends in screening and assessing comorbidity risk.

Main Methods:

• Literature review of existing guidelines and research on comorbidities in inflammatory arthritis.
• Analysis of the impact of comorbidities on patient outcomes and clinical practice.
• Examination of current trends in comorbidity screening and risk assessment.

Main Results:

• Despite improved prognoses, inflammatory arthritis patients have higher mortality rates due to comorbidities.
• Implementing comorbidity assessment and management guidelines remains a significant challenge for clinicians.
• There is a need for updated strategies in screening and assessing comorbidity risk.

Conclusions:

• Comorbidity management is critical for improving the longevity and quality of life for patients with inflammatory arthritis.
• Addressing the gap between guidelines and clinical practice is essential for effective patient care.
• Further research into dynamic comorbidity assessment is warranted.